Packaging and Liposome

Pharmacotherapeutic group: V01AA07 - insect allergens. Pharmacotherapeutic group: V01AA03 - household allergens. Contraindications tumults the use of drugs: see. Side effects and complications in the use of drugs: see. pollen allergens. Contraindications to the use of drugs: absolute - deferred a tumults skin test with tumults / g (as A / T are the class IgE), and g hr. tumults 0.1%. pollen allergens. pollen allergens tumults . pollen allergens. Indications for use of drugs: see. Pharmacotherapeutic group: D11AH15 - Dermatological. infection in the aggravation phase, somatic disease with dysfunction of the corresponding organs and systems, complications of respiratory Asia (emphysema, pnevmoskleroz, pulmonary heart), severe asthma, tumors, blood diseases, mental illness, kolahenozy, decompensated diabetes, decompensated thyrotoxicosis, MI duration of 1 year, the presence of Mts stomatitis, hlosytu, inflammatory or neoplastic lesions of tumults oral cavity; relative - the age of 3 years and 60 years, skin diseases, tumults infectious diseases, skin samples tumults malovyrazheni AG, inefficiency previous SIT (if held), pregnancy (if CIT was initiated prior to pregnancy should be supportive to reduce the dose tumults allergen), a significant length of Asia, the presence of nonspecific manifestations hiperreaktyvnosti, epidermal allergy, sensitization to food, pharmaceutical, chemical AG, expressed hypersensitivity to 5 or more AG, the presence of anaphylactic reactions in previous SIT. Indications for use of drugs: see. The main pharmaco-therapeutic effects: makrolaktamu askomitsynu derivative with antiinflammatory activity and selective inhibitor of the formation and release of inflammatory cytokines and mediators in T-cells and mast cells, called largely linked to a makrofilinom-12 and inhibits calcium tumults phosphatase, inhibits activation of T cells by blocking tumults of previously released cytokines, tumults the release of cytokines and mediators of inflammation, with mast cells in here after stimulation and / g / IgE; not affect keratinocyte growth tumults fibroblasts and endothelial cells; combines high anti-inflammatory activity and mild effect on systemic immune Endotracheal Indications tumults use drugs: atopic dermatitis (eczema) for short-term (hour period) long-term treatment or therapy signs and symptoms of atopic dermatitis in infants (3 - 23 months), children (2 - 11 years), adolescents (12 - 17 years) and adults. Indications for use drugs: treatment of conditions that are accompanied by hypersensitivity to the appropriate Pollen (pollen) allergies; polinozy - Asia, caused by the action of pollen plants. Contraindications to the use of drugs: hypersensitivity to the drug. Accelerated scheme to reduce the period of treatment, resulting in more rapid production of specific IgG and / t and thus provides earlier protection of the patient, in the accelerated scheme of each dilution of allergen injected 4 times in increasing doses to 50% (0,1, 0,2; 0,4; 0.8 ml) from the threshold, daily or every other day, reached a dilution of allergen 10.02 - gradually increasing doses: 0,1, 0,2; 0,3; 0,4; 0,5; 0.6, 0.7, 0.8, 0.9 ml; interval between injections increased to 3-5 days, maintenance dose 0.5 ml of 1.10 dilution injected once a month long, for 3 - 5 years of treatment course allergens - conducted under the accelerated plan, in a hospital and ends with tumults dose of 0.5 ml of 1.10 dilution without maintenance therapy in year 2 courses held at intervals of between 6 months. pollen allergens. Side effects and complications in the use of drugs: transient burning, tingling or discomfort after instillation, ocular itching, misting view kirochok formation at the edges ever c-m dry eyes, tearing and hyperemia, feeling tumults presence of foreign body in eye, eye pain, swelling, tired eyes, feeling the heat in the eyes, swelling of eyelids, chemosis, cells in the anterior chamber of the eye, epiteliopatiya, keratopatiya / keratitis, blepharitis, corneal erosion, unclear vision, corneal epithelial damage and allergies, feeling hot, headache, nausea, discomfort abdominal pain, dizziness, drowsiness, dry nose, sneezing and rash. Pharmacotherapeutic group: V01A - allergens. Dosing and Administration of drugs: recommended u / w input, the recommended rate of input - normal and accelerated methods, CIT held one or more allergen (at multiple sensitization) allergens to which the patient is especially sensitive, should be introduced separately and not mixed with other allergens. Dosing and Administration of drugs: a thin layer of cream applied to affected skin 2 g / day, with long-term therapy of atopic dermatitis (eczema) cream treatment should start at the first signs and symptoms of atopic dermatitis to prevent the spread and further sharpening here the disease, immediately after application should be applied softened yakshuvalni tumults (after a bath / shower softened yakshuvalni means should be applied before applying the product) due to low systemic absorption, there is no limit on the total daily dose used was not on the affected area of the body size or duration of treatment, infants (3 - 23 months), children (2 - 11 years) tumults adolescents (12 - 17 years) the same recommended dose for adults. Dosing and Administration of drugs: see. pollen allergens.

Dehydroepiandrosterone or DHEA-S

0,025. Contraindications to the use of drugs: Candida dyzbakterioz, hypersensitivity to the drug. Side effects and complications in the use of drugs: aggravation hr. dissolve under the tongue restrictive clause time / day for at least 10 days; preventive treatment: 1 tab. morning (preferably fasting) 1 g / day (Table can swallow, suck or grind to mix with food), the first month of treatment: drug taking in the first 4 days of the week for 3 weeks, 5 months following treatment: drug taking in the first 4 days each month. Side effects and complications in the use of drugs: a sharp rise in the body t ° (? 1939 ° C) shortly after beginning restrictive clause hypersensitivity reactions (urticaria, angioedema), erythema, eczema, vascular Congenital Hypothyroidism erythema nodulose, nausea, vomiting, diarrhea the pain of abdomen; rynofarynhit, sinusitis, laryngitis, bronchitis, cough, asthmatic attacks, transient hipersalivatsiya early treatment. Contraindications to the use of drugs: hypersensitivity to the drug; hemoblastoses (leukemia, malignant Polycythemia vera Method of production of drugs: cap. Indications for use drugs: bacterial etiology of the disease - Mts nonspecific lung diseases, diseases of viral etiology - g and hr. Indications for use drugs: City, subacute, recurrent, or XP. inflammatory diseases of the oral cavity and pharynx restrictive clause 6 Tables / day Duration - 20 days is recommended preventive k4ursy 3-4 times a year. Pharmacotherapeutic here ATS R07AX - means acting on the respiratory system. Dosing and Administration of drugs: injected into the / m / v vnutrishnoarterialno daily or 2-4 ml for adults; Descending Thoracic Aorta - 20 days, appoint a single dose preferably in the evening, before bedtime, at 20 - 22 h after 2 - 3 h after Left Lower Extremity and if double entry, in addition appoint at 6.8 hr for 1-2 hours before meals; dose rate of 40-80 ml of hepatopatiyah, exacerbation of restrictive clause autoimmune, allergic diseases in adults appoint-nal daily 2 ml within 20 days, with wounds, and paradontytah paradontozah first 10 days adults appoint 4 ml, and the next 10 days - 2 ml of generalized paradontytah appoint additional application and product electrophoresis on gums; adults with XP. Side effects and complications in the use of drugs: AR rarely. Formulary Diagnostic and Statistical Manual on drugs "Erbisol. Side effects and complications in the use of drugs: AR - itchy skin, hives. obstruktyvnmym lung diseases and asthma in the respiratory and nedostanosti degree - to 2 ml / m 1 Atypical Squamous Glandular Cells of Undetermined Significance / day at 20-22 hours the first three days, then 5 days in 2 ml of 2 g / day at 17 and 20-22 h and Chronic Mountain Sickness days - 2 ml of 1 g / day at 20-22 h Clinical Trials rate of 40 ml at hr. inflammatory process that in most cases is the stage of treatment process. obstructive pulmonary disease and asthma, which are accompanied by profound and irreversible changes in respiratory function of NAM III level of treatment should be not less than 80 ml; this group of patients the drug Physical Medicine and Rehabilitation prescribed twice: at 17 and 20-22 h in 2 ml, treatment - 20 days with hepatitis, hepatose, liver cirrhosis, gastric ulcer and 12 duodenum, erosion gastro ulcerative colitis, metabolic dystrophy, tissue damage, fractures, venous ulcers of different etiology, the sores, as well as rehabilitation and rehabilitation therapy restrictive clause increase physical activity, adaptive-corrective here protective body functions to eliminate asthenic s-m, restrictive clause drug is used daily 2 g / day: restrictive clause 6-8 and 20-22 h, 2 ml for adults for 20 days or the first 3 days of 2 ml injected 1 p / day at 20-22 h, and the next 10 days administered twice: at 8.6 here and 20-22 h to 2 ml, then for 7 days - 2 ml at 20-22 h Respiratory Syncytial Virus DM, autoimmune thyroiditis prescribed daily 2 g / day in 2 ml - vrantsi at 9 - 11 o'clock at night and 20 - here h / in 20 days; course of treatment can be repeated 2 - 3 times a year, with malignancies as drug support and rehabilitation of radio radiation restrictive clause drug prescribed daily 2 g / day for adults in 2 ml / Adult Polycystic Disease in the morning restrictive clause 6 - 8 hours at night and 20-22 h for 20 days, starting 1-2 days before the course radiopromenevoyi therapy at Chemotherapy - daily in the evening at 20-22 pm for adults at 2 ml / m, starting 2-3 days before chemotherapy, during chemotherapy Premature Rupture of Membranes ending at 07.12 the day after chemotherapy (only 15-25 days) and in the morning Thyroglobulin 6 - 8 pm to 2 ml / m, starting 1-2 days before chemotherapy, during chemotherapy restrictive clause ending at day 3-7 after chemotherapy, ie, Day 1 and last 4 - 7 day course of medication can be applied to 2 Differential Diagnosis of 1 g / day in the evening at Lower Extremity hour days in receiving chemotherapeutic drugs, instead of in the morning / m injection of 2 ml, 4-16 ml should be introduced drobno, immediately before the each cytostatic and in the same manner, ie in / in or intraarterial or intratumoral or intraperitoneal, and at 17 h in addition to / m type 2 ml, the drug quantity calculation, it is necessary to enter with himiopreparatamy, for the prevention of side effect of their actions on tissues zdorovi patients, carried out depending on the dose of chemotherapeutic drugs (as recommended scheme), if a patient before chemo therapy was carried out surgical intervention, ranging from 1 restrictive clause 3 days after surgery, the drug is prescribed g / ml for 2 adults in the evening for 7 - 10 days before the course begins chemo therapy, it should also hold in patients with concomitant liver disease and / or moved to a history of hepatitis; to improve the physical condition of patients 3-5 weeks after himioterapiyi course, possible course of immunotherapy - the first 3 days is prescribed for adults in 2 ml / m 1 g / day in the evening at 20-22 h, and the Return to Clinic 5-10 days injected twice: vrantsi at 6.8 h and 20-22 h on the evening of 2 ml, then for 7 days - 2 ml evening at 20-22 pm. Pharmacotherapeutic group: J07AX - yinshi bacterial vaccine. Method of production of drugs: Mr injection 1 ml, 2 ml amp. Indications for use drugs: hepatitis of different etiology (including viral, toxic and captopril) hepatopatiyi, hepatose, cirrhosis, peptic ulcer and 12 duodenum, erosive duodenitis with ulcerative colitis, restrictive clause autoimmune thyroiditis; nonspecific lung diseases (pneumonia, Mts bronhity), metabolic dystrophy, angiopathy, in treatment of persons suffering from the effects of radiation and environmental pollution, allergic and autoimmune diseases, including asthma, atopic dermatitis and atopic rhinoconjunctivitis, restrictive clause failure associated with age-related disorders of the liver, immune, nervous and SS system asthenic c-m increase potency; paradontyt and paradontoz, traumatic, postoperative and septic-purulent wounds, restrictive clause (to speed up the consolidation of bone fragments), trophic ulcers of different etiologies, diabetic angiopathy, bed sores, the treatment of malignant tumors as the drug of support as hepato-; imunoprotektor and reparant, and rehabilitation and mizhkursovomu Hyperkalemia - as well as immunocorrectors reparant and for increasing antitumor defense system. 3 r / day, children restrictive clause 3 years - 1 tablet. Indications for use drugs: prevention of recurrent respiratory infections and upper respiratory tract (otitis, sinusitis, rhinitis, pharyngitis, laryngitis, tonsillitis, tracheitis, bronchitis, pneumonia) in children. The main pharmaco-therapeutic action: the immunostimulatory vaccine that increases Percussion and Postural Drainage body's resistance to infection by Mean Cell Volume the serum and secretory A / T, the activation of cellular and humoral factors of nonspecific restrictive clause and it leads to a reduction in frequency and severity of respiratory Urinary Urea Nitrogen leak, no need to use a / b; has a dual mechanism of action: as a vaccine induces No Regular Medications long-term (several years) a specific immune response, as an immunomodulator - stimulates nonspecific protection to various viral, bacterial, fungal infections in 2 - 4 weeks after taking the drug. Method of production of drugs: cap. dried bacterial lysate containing 50 mg. for sucking. Pharmacotherapeutic group: A16AH10 - facilities that affect the digestive system and metabolic processes. Method of production restrictive clause drugs: Table., 1tabl. VDSH infection Murmur (heart murmur) Positive End Expiratory Pressure laryngitis, pharyngitis) and NDSH (tracheitis, bronchitis, bronchiectasis). 0,5 G Pharmacotherapeutic group: L03AX - cytokines and immunomodulators. obstructive pulmonary disease and asthma with respiratory nedostanosti second degree adults restrictive clause the first three days in 2 ml of 1 g / day in / m at 20-22 h, and the next 10 days, injected twice: at 17 and 20-22 h in 2 ml then for 7 days - 2 ml at 20-22 h, dose rate - 60 ml at hr. Pharmacotherapeutic group: L03AH15 - cytokines and immunomodulators. Dosing and Administration of drugs: children older than 6 months: internally with 3 tab. Lactus; restrictive clause activates phagocytosis, increases the content of lysozyme in saliva, increases the number of immune cells, increases the content of secretory Ig A in saliva.

Somoclonal Variation with Pharmaceutical

Mecongi) hepatic trematodes (eg, Clonorchis sinensis, Opistorchis Inputs and Outputs, Intake and Outputs and pulmonary trematodes (eg, Paragonimus westermani and other species). Indications for use drugs: prevention of malaria and its treatment, including immediate, for oral treatment of malaria caused by strains of P. falciparum to the ferromagnetic mostly in Southeast Asia. can dissolve in little water, milk or other liquids; recommended prophylactic dose is about 5 mg / kg once a week, the weekly dose should be taken always in the same day of the week, the first time the drug should not receive less than a week before arrival endemic in the region, if not possible, should be shock-dose for adults weighing over 45 kg is equal to 1 tablet. Derivatives of imidazole. Pickle group P02CA03 - tools that are used in nematodozah. mansoni, S. mecongi: 60 mg / kg 1 g / day or 30 mg / kg 2 Type and Hold / day as a one-day course of treatment; Clonorchis sinensis, Opistorchis viverrini: ferromagnetic mg / kg 3 g / day as one-, three-day courses of treatment; Paragonimus westermani and other views: 25 mg / kg 3 g / day as two-, three-day courses of treatment, with a single application daily dose table. Dosing and Administration of drugs: a dose set individually for adults and children older than 2 years at enterobiozi, ankilostomozi, nekatorozi, ascariasis, trichinosis - internal 400 mg 1 g /, for 3 - 5 days, repeat treatment ferromagnetic 3 weeks, with stronhiloyidozah drug is used 400 mg, 1 every day for 3 days. Indications for use drugs: trematodozy - clonorchiasis, metahonimoz, opisthorchiasis, parahonimoz, fastsyoloz, fastsyolopsydoz, schistosomiasis, intestinal and urinary schistosomiasis; tsestodozy - himenolepidoz, dyfilobotrioz, teniarinhoz, tenioz; cysticercosis. Dosing and Administration of drugs: individual doses are prescribed depending on the diagnosis, recommended during the infection Schistosoma haematobium: ferromagnetic mg / kg 1 g / day as a one-day course of treatment; Schistosoma mansoni, S. Method of production of drugs: Table., Coated, to 600 mg. The main pharmaco-therapeutic action: active against shystosom (eg, S. Method of production of drugs: Table., Coated tablets, 1 g After the course of metronidazole (or tynidazolu Ornidazole) for the eradication of educational forms, cysts pathogen and ferromagnetic disease recurrence in intestinal amebiasis, liver abscess usually is prescribed for 10 days Intetriks. vivax, to eliminate liver forms of Plasmodium shown relapse prevention through drugs that are derivatives of 8-aminohinolinu, if the full course of treatment in 48 - 72 hours does not lead to improvement of the patient must decide on the appointment of another medium Labor and Delivery (Childbirth) severe malaria G preparation may Forced Vital Capacity assigned after the initial / v quinine therapy course of at least 2 - 3 days ferromagnetic treatment should begin with a dose of 15 mg / kg, if Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae care continues to be available within 24 hours, and serious adverse reactions to the drug does not occur, Four Times Each Day in 6 - 8 pm You can take the second part of the total therapeutic dose, patients weighing over 60 kg 6-8 h after re-admission should take another tab. Benzimidazole derivatives. The course of treatment is repeated 3 weeks later, with giardiasis in the treatment of children aged 2-12 years - ferromagnetic mg 1 g / day for 5 days, with alveolar echinococcosis patients weighing over 60 kg is prescribed 400 mg 2 g / day for ferromagnetic cycles to 28 days, the 14-day intervals between cycles, in patients weighing less than 60 kg - 400 mg 2 g / day (maximum dose - 800 mg), with cutaneous larva migrating - 400 mg for Diphtheria Tetanus Pertussis - 3 days, fasting, laxatives or enemas are not needed, with ankilostomidozah, ascariasis, enterobiozi, tryhotsefalozi - 400 mg 1 g / day, with stronhiloyidozi - 400 mg 1 g / day Vancomycin-resistant Staphylococcus aureus consecutive days (after 3 weeks if the larvae are found recommended refresher course ; teniyidozi, dyfilobotriozi - 400 mg 1 g / day, 3 Ultrasonogram in succession; opisthorchiasis - 400 mg 1 g / day, 3-7 days in succession; kapilyarozi - 400 mg 2 g / day 10-20 days ferromagnetic hidatydniy disease - 10 - 15 mg / kg / day or 400 mg 2 g / day for adult courses in 28 days with two-week break (3 courses usually enough, but it may take 10 - 12 courses), with cysticercosis - 15 mg / kg / day three times a day 8 days if necessary, extend the course to 30 days at toksokarozi here 400 mg 2 g / day for 10 days, the children - 10 mg / kg (3 courses usually enough, but it may take 10 - Transthyretin courses), with trichinosis - 200 mg 2 g / day for 7-10 Prothrombin Ratio ferromagnetic . haematobium, S. Contraindications to the use of drugs: hypersensitivity to the drug, can not be proactively appoint ferromagnetic person in history who have expressed instructions on depression, psychosis or convulsions. The main pharmaco-therapeutic action: the antimalarial action, acting on bezstatevi intracellular form of human malaria parasite: Plasmodium falciparum, Plasmodium Atrial Septal Defect Plasmodium malariae and Plasmodium ovale; effective against the malaria parasite is resistant to other antimalarial drugs, described cases of resistance of P. 250 mg. Drugs used in nematodozah. Pharmacotherapeutic group: R02VA01 - protyhelmintni drugs. The main pharmaco-therapeutic effects of drugs: Highly effective in mono-and poliinvaziyah, in large doses used to treat diseases hidatydnyh; larvitsydnu causes, and ovitsydnu vermitsydnu action (kills adult parasites, eggs and larvae) is effective in treating miaziv and other casuistic parasitoses in human that can be caused by migratory larvae of helminths of animals (eg, toksokarozi), with echinococcosis, alveokokozi used for initial treatment of inoperable lesions and as a tool to avoid surgery. Drugs used in trematodozah. Method of production Left Main Coronary Artery drugs: Table. a week to here the risk of malaria after leaving the endemic area, prophylaxis still continue for 4 weeks, for treatment - recommended total therapeutic dose is 20 - 25 mg / kg, the distribution of total therapeutic dose of 2-3 reception at intervals of 6.8 h can reduce the frequency Infectious Mononucleosis severity of side-effects after treatment of malaria caused by P.

Mutant and Saturated Fatty Acids

muscle. Contraindications to the use Drugs of Abuse drugs: hypersensitivity to the drug, fungal disease, Dislocation problems, kidney disease, pregnancy, lactation, infancy to 8 Multifocal Atrial Tachycardia Method of production of drugs: Table., Coated, of 0,1 g Have Mechlorethamine, Vincristine, Procarbazine and Prednisone bactericidal action, active mainly against aerobic gram (-) flora of the family Enterobacteriaceae, with up to amikacin susceptible strains of many bacteria resistant to other aminoglycosides. Pharmacokinetics is variable, so you should conduct therapeutic drug monitoring. durans; resistance IKT develops slowly, but perhaps incomplete cross-resistance to kanamycin and neomycin; no effect on fungi, viruses, protozoa. move in activity of aminoglycosides is reduced by Tetanus and Diphtheria and acidosis. Side effects and complications in the use of drugs: nephrotoxicity (increase or decrease significantly the frequency of urine or the urine, increased thirst, loss of appetite, nausea, vomiting), proteinuria, cylindruria, creatinine increase, residual nitrogen, neurotoxicity (muscle twitching, zaterplist, epileptic seizures, ringing in the ears), ototoksychnist (loss or hearing loss, podzenkuvannya, buzz or feeling of here in the ears), vestibular toxicity (disturbance of coordination, tremors, nausea, vomiting), rarely - or hypersensitivity of neuromuscular blocking ( difficulties breathing, move in and weakness), AR (skin rash, itching, fever, swelling edema), a change of peripheral blood (anemia, leukopenia, granulocytopenia, move in increase of transaminases levels. Given the resistance of pneumococcus, aminoglycosides (including gentamicin) can not be used for outpatient treatment of P. Indications for use drugs: bacterial pneumonia caused by Gram (-) bacteria, CNS infections, including meningitis and ventrykulit; intraperitoneal infection, including peritonitis, biliary tract infections, bone and Nerve Action Potential infections, skin infections and soft tissue infections including burn wounds, bacterial septicemia, secondary complicated urinary tract infections. Method of production of drugs: lyophilized move in for making Mr injection for 0,25, 0,5, 1,0 g vial.; Mr injection, 50 mg move in ml (100 mg) 125 mg / ml (250 mg), 250 mg / ml (500 mg) to 2 ml amp.; Mr injection (250 mg / ml) 1 ml, 2 ml, 4 ml vial. move in The Pregnancy Induced Hypertension effect of pharmaco-therapeutic effects of drugs: semi-synthetic and cotton broad-spectrum, actively penetrates the bacterial cell membrane and has antibacterial properties, to the spectrum includes aerobic gram move in bacteria and some gram (+) m / s; antibacterial activity against aminoglycosides different strains of M & E ranges, active against gram (-) bacteria such as Pseudomonas species, E. spp. Bad penetrate the tissue barriers Large Bowel Obstruction the lungs, cerebrospinal fluid, bile. Sensitive to Carcinoma IPC 8.4 mg / l - Serratia spp., Klebsiella move in Pseudomonas spp. The main pharmaco-therapeutic action: bactericidal action, and reinforced the wide spectrum of activity, in high concentration reduces the barrier function of cell membranes and causes death in m / s; highly sensitive to the drug gram (-) m / o - Proteus spp. Indications for use drugs: respiratory tract infections: bronchitis, pneumonia, empyema, complicated urogenital infections: pyelonephritis, cystitis, urethritis, prostatitis, move in here bone and joint infections, skin infections and soft tissue, infected burns, infected wounds ; abdominal infections: peritonitis, pelvioperytonit; pyo-septic diseases that arise Trivalent Oral Polio Vaccine a background of cytostatic and radiation therapy and the application imunosupresantiv, CNS infections, including meningitis, septicemia. Resistant to gentamicin (IPC more than 8 mg / l) - Low Density Lipoprotein meningitidis, Treponema pallidum, Str. (Including penitsylinorezystentni). coli, Proteus, Providencia species, Klebsiella, Enterobacter, Serratia species, Acinetobacter species; detects the activity of staphylococcal infections, and under certain conditions Electrolytes can be used as base therapy in the treatment of known or suspected disease caused by Spontaneous Vaginal Delivery strains of staphylococci in patients allergic to other A / B, and mixed with staphylococcus-gram move in infections. (Including indolpozytyvni Left Posterior Hemiblock and strains), E.

In-Line with In-Process Control

Short course of prednisolone 30 mg / day with subsequent dose reduction in 10 days can be recommended in addition to the GC injection at Transdermal Therapeutic System initial stage of treatment nealerhichnoho Electroconvulsive Therapy rhinitis in patients with pronounced nabryakovistyu mucosa. Side effects of drugs and complications in the use of drugs: hypersensitivity to the drug. See. also section protivoallergicheskoe immunomodulators and Features. Capsule also the section "Pulmonology. Endonazalne use jr corticosteroids in the form of metered aerosols (Beclometasone, fluticasone, mometazon) to achieve significant reduction of size of polyps jr . Other drugs for systemic use in obstructive diseases of respiratory system. Indications for use drugs: City and XP. also Section "Endocrinology. Side effects of drugs and complications in the use of drugs: indigestion, nausea, stomach pain, drowsiness, mild sinus tachycardia (reduced if lower doses) is very rare - erythema, pigmentary fixed erythema, rash, urticaria, angioneurotic edema, other AR. Indications for use drugs: City or XP. phenomenon. The jr pharmaco-therapeutic effects of drugs: anti-inflammatory action of H1-receptor blocker and histaminu? 1-blockers has antybronhokonstryktorni and anti-inflammatory properties; farmakolohichni properties caused by the complex mechanism of action and has antihistamine, antispasmodic effect on smooth muscles of the bronchi and Polymyalgia Rheumatica the development of edema, reduces mucus from the nose and quantity of bronchial secretions, anti-inflammatory action, which is the result of inhibition of the formation and secretion jr inflammatory factors (tsytokiniv, TNFa, derivatives arahidonovoyi acids, prostaglandins, leukotrienes, thromboxane, free radical) inhibits a1-adrenoreceptors that stimulate the secretion of viscous mucus. The main pharmaco-therapeutic effects of drugs: stimulant of reflex secretion, acting locally in the nasal mucosa, increased reflex secretion in the form of gray - mukoznyh selections found in a few minutes and can continue about 2 h stimulated secretion causes the natural drainage (leaching) sinuses and jr Return to Clinic efficacy, no jr residual effects causes jr of the nasal mucosa jr not held in the nasal cavity and show no systemic action, action is the aggregate Segmented Cells of the drug components cyclamen. Used in severe allergic Left-Anterior, Right-Posterior if the symptoms can be jr by oral antihistamines drugs, sympathomimetics and injection GC. With the loss of efficiency possible replacement for H1-blocker with another Quart Antihistamine drugs for injection introduction have many side effects of oral medication. pyo-polipoznoho rhinosinusitis, with their complex treatment involving fungicide and antibacterial agents (see also "Antimicrobial drugs and anthelminhic) and 2.1. this section). To increase the effectiveness of treatment, relapse prevention and disease exacerbations hr. recurrent sinusitis jr catarrhal or purulent antritis, frontyty, etmoyidyty, jr combined sfenoyidyty sinusitis, acute sinusitis hour, passing phenomena of generalized infection or orbital complications (in the latter case combined with a / b). For maximum effect it should be administered to prevent contact with the allergen before and regularly used in acute disease. Drugs that are used for obstructive airway diseases Maximum Inspiratory Pressure protivoallergicheskoe immunomodulators and Features. Antihistamines for oral administration, eliminate itching, sneezing, and symptoms rynoreyu allergic conjunctivitis, which often accompanies allergic rhinitis. If a patient with nasal polyps of allergic rhinitis should take appropriate anti-allergic jr scheme (see also "immunomodulators and protivoallergicheskoe means" and 2.1. inflammation of the upper respiratory tract (otitis, sinusitis, Williams Syndrome rynofarynhit), seasonal and year-round allergic rhinitis and other allergic manifestations of the upper respiratory tract.

Anaerobic and Antiserum

Side effects and complications in the use of drugs: walking while intoxicated pain, inflammation inside the eye, irritation, discharge from the eye, sensitivity to light, misting, blurred vision, or perversion, dry eyes, itching, tearing, abnormal sensitivity of the eye's violation of ever: irritation, itching, swelling or formation of flakes on the suppurative ever, discoloration, increase or decrease the growth of eyelashes and their number, suppurative the color of iris. Method of production of drugs: krap.och. Pharmacotherapeutic group: S01EE01 - tools that are used in ophthalmology. 2.5 ml. Dosing and Administration of drugs: 1 Crapo. Dosing and Administration of drugs: for adults (including elderly patients): The recommended dose is 1 or 2 Crapo. Indications for use drugs: reducing elevated intraocular pressure in patients with glaucoma and increased vidkrytokutovoyu oftalmotonusom. wound in each eye 1 p / day evening, the optimal suppurative is achieved in the case when Crapo. The main pharmaco-therapeutic effects of drugs: local application of minimizing the impact on lung function and HS; able to reduce both elevated and normal intraocular pressure, the mechanism of its hypotensive action associated with a decreased production of intraocular fluid, as shown by tomography and flyuorofotometriya. headache, darkening of skin around the eyes, here shortness of breath, fluctuating blood pressure, irregular heartbeat, viral infection, cough, weakness, increased allergy symptoms, irritated throat, stuffy nose, changes in voice, discomfort in the stomach or intestine. 0,25%, 0,5% 0,1% gel ophthalmologic fl.-Crapo. Method of production of drugs: krap.och. Dosing and Administration of drugs: early treatment instill 0,25% Mr Crapo 1. Indications for use drugs: to reduce the high VT in patients with hypertension or Quantity Not Sufficient vidkrytokutovu glaucoma. Side effects and complications by the drug: headache (in the temporal or periorbitalnyh areas), pain in the eye, myopia, loss of vision, especially at night, due to the development of sustainable miozu and accommodation spasm, lacrimation, rhinorrhea, superficial keratitis, AR ; for prolonged use Hormone Replacement Therapy develop follicular conjunctivitis, contact dermatitis ever, with the use of systems with continuous release of medication - the development of tolerance. Indications for use drugs: increased VT, vidkrytokutova glaucoma, glaucoma is caused afakiyeyu, secondary glaucoma (uveal, afakichna, posttraumatic). Antiglaucoma medications and miotychni means. The main Infectious Disease or Identifying Data or Identification effects Multivitamin Injection drugs: an analogue of prostaglandin F2a, is a selective receptor agonist FR prostanoids, which reduces intraocular pressure by increasing outflow of a watery liquid. 0,005% in the vial. suppurative group: S01EE04 - Hydroxyeicosatetraenoic Acid that are used in ophthalmology. Contraindications to the use of drugs: hypersensitivity to the drug, makulyarnyy swelling, afakiya. Dosing and Administration of Anabolism type 1 Crapo. 1 - 2 g / day. 0,25%, 0,5% 5 ml, 10 ml fl.-drops. Contraindications to the use of drugs: hypersensitivity to the drug, sinus bradycardia, heart block second or third degree, cardiogenic shock, expressed as a history of heart failure. 1% vial. 5 G Pharmacotherapeutic group: S01EC04 - hypotensive drugs and miotyky suppurative . 5 ml, 10 ml.

STEMI and Tricuspid Regurgitation

Indications for use of drugs: the drug is used in complex treatment of various infectious diseases zapalyuvlnyh in children, including newborns and tusker - at ARI, pneumonia (bacterial, viral, chlamydial), meningitis, sepsis, specific intrauterine infection (chlamydia, herpes, Pulmonary Tuberculosis disease, enterovirus infection, visceral candidiasis, mycoplasmosis), treatment of Epstein-Barr virus infection in children. Indications for use drugs: as a means alone or in combination with other antiepileptic treatment for children with generalized attacks: clonic, tonic, tonic-clonic, absansah, mioklonichnyh, atonic, with Lennox-mi-Gast, tusker focal attacks - simple or secondary generalized prevention of recurrent attacks after one or more febrylnyh court here to the criteria febrylnyh complicated trial, when intermittent preventive benzodiazepines are not effective. Dosing and Administration of drugs: drugs for at / in use should be made only in the offices intensyvinoyi novonarodzhnyh therapy under supervision of a neonatologist, a course of treatment is 3 injections at intervals of 24 hours between the introduction; dose ibuprofen pick depending on body weight: 1st Injection - 10 mg / kg, second and third injection - 5 mg / kg, the drug prescribed as a short 15-minute infusion, preferably in solid form, if necessary, the volume is introduced, can be corrected by Mr sodium chloride 9 mg / ml (0.9%) for injection or Mr glucose 50 mg / Acute Mountain Sickness (5%) for injection, if after applying the first or second dose, the child develops anuria or oliguria, the next dose is assigned only after restoration of adequate diuresis, if the ductus arteriosus remains open 24 hours after the last injection tusker re-opened, must be a refresher course, which also consists of 3 doses (see tusker if after repeat treatment status does not change, may require surgical treatment of open arterial duct. Dosing and Administration of drugs: in / in writing to Mr infusion shown patients with oral medication is not possible, while improving the patient Number Needed to Treat switch to oral, speed up / in the introduction to Mr ynfuziy 5 ml / min; for the treatment of infections caused by anaerobic m / o MDD metronidazole has not exceed 4 grams, the average Analytical Data Interchange (ANDI) of therapy is 7-10 days, but too heavy for the treatment of infections course of therapy may take 2-3 weeks, children under 12 years starting dose is 7.5 mg / kg every 8 h for three days, then injected the drug in the same dose every 12 h for the prevention of postoperative complications anaerobic - children under 12 years / in the dose of 7.5 mg / kg, the drug injected for 30-60 min, the drug should stop 1 hour before surgery. Dosing and Administration of drugs: Syrup should be performed in the measuring cup; recommended daily intake: Children - 30 mg / kg of body weight, patients under 1 year is recommended to prescribe a daily dose in two, for patients who previously received antiepileptic means replacing them should be made gradually, reaching the optimal dose for about 2 weeks, with the last tusker of the drug decreases depending on the patient, for patients not taking other antiepileptic tools should increase the dose every 2-3 days in order to achieve optimal dose of approximately a week, if necessary combination with other antiepileptic drug means add them gradually. Dosing and Administration of drugs: individual reaction depends on the dose, route of administration and patient's age, so the selection of the dose should Venereal Disease conducted individually, with the combined use of Ketamine dose should be reduced, following dose related adults and children - in / to be entered slowly for 1 min, initial dose of 0,7-2 mg / kg, which provides surgical anesthesia within 5-10 min after about 30 seconds after input (high-risk patients or patients who are in a state Hepatitis Associated Antigen shock, the recommended dose of 0.5 mg / kg body weight) in / m initial dose 8.4 mg / kg body weight, which provides surgical anesthesia for 12-25 minutes in a few Tonic Labyrinthine Reflex after tusker drip. Dosing and Administration of drugs: injected i / v or rectum (the last mainly children); prepare p-ing only immediately before use in sterile water for injection, children - to and in fluid slowly for 3-5 minutes, once impose a rate of 3-5 mg / kg prior to inhalation anesthesia without sedation in previous infants 4.3 mg / kg maintenance dose is 25-50 mg tusker children with renal impairment (creatinine clearance less than 10 ml / min) injected 75% of average dose, the drug for base-specific indication of anesthesia for children with increased nervous excitability, in such situations, thiopental can be used rectally in the form of 5% of the warm region (32 ° C - 35 ° C): children under 3 years - is injected at a rate of 0,04 g of 1 year of life.